Search

everythinglearnresearchcommunity

for

Search:↓

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

RTA 408 cream protects mice from radiation skin damage.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The best way to treat acne is to prevent healthy skin glands from turning into acne lesions by controlling the triggers early on.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Androgens significantly affect female hair loss, and hormonal treatments may help.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Minoxidil effectively controls blood pressure but side effects may limit its use.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.